INCY

Incyte Corp

Performance

Today’s LowNA
    Today’s HighNA
    52W LowNA
      52W HighNA
      Open PricePrev. CloseVolumeAvg. Volume
      NANANANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $18.95 B8.10NA$17.67 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA10.78-0.89-8.20%

      About the Company

      Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera can
      Organisation
      Incyte Corp
      Industry
      Biotechnology
      Headquarters
      Wilmington, DE
      ABOUT GROWW
      keyboard_arrow_down